0001562180-24-001290.txt : 20240213 0001562180-24-001290.hdr.sgml : 20240213 20240213173759 ACCESSION NUMBER: 0001562180-24-001290 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240209 FILED AS OF DATE: 20240213 DATE AS OF CHANGE: 20240213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Duker Jay S. CENTRAL INDEX KEY: 0001630864 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51122 FILM NUMBER: 24630379 MAIL ADDRESS: STREET 1: C/O ELEVEN BIOTHERAPEUTICS STREET 2: 215 1ST ST. #400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EyePoint Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001314102 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 262774444 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 480 PLEASANT STREET STREET 2: SUITE B300 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-926-5000 MAIL ADDRESS: STREET 1: 480 PLEASANT STREET STREET 2: SUITE B300 CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: pSivida Corp. DATE OF NAME CHANGE: 20080619 FORMER COMPANY: FORMER CONFORMED NAME: pSivida LTD DATE OF NAME CHANGE: 20050111 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2024-02-09 false 0001314102 EyePoint Pharmaceuticals, Inc. EYPT 0001630864 Duker Jay S. C/O EYEPOINT PHARMACEUTICALS, INC. 480 PLEASANT STREET WATERTOWN MA 02472 true true false false President and CEO false Common Stock 2024-02-09 4 M false 7000.00 0.00 A 50486.00 D Common Stock 2024-02-09 4 M false 4967.00 0.00 A 55453.00 D Common Stock 2024-02-09 4 F false 2075.00 28.80 D 53378.00 D Common Stock 2024-02-09 4 F false 1458.00 28.80 D 51920.00 D Restricted Stock Units 0.00 2024-02-09 4 M false 4967.00 0.00 D 2031-02-09 Common Stock 4967.00 0.00 D Restricted Stock Units 0.00 2024-02-09 4 M false 7000.00 0.00 D 2032-02-09 Common Stock 7000.00 7000.00 D No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units The restricted stock units will vest in three ratable annual installments beginning February 9, 2022. The restricted stock units will vest in three ratable annual installments beginning February 9, 2023. /s/ Ron Honig, Attorney-in-Fact 2024-02-13